Latest filing published 20 Apr 2012 for SERACARE LIFE SCIENCES INC.
No signal scores available.
This profile gathers the share dealings of Joseph M. Nemmers across 2 companies, led by Abbott Laboratories and Seracare Life Sciences Inc. In total, 36 filings cover trades dated from 22 December 2005 to 20 April 2012.
Sales make up the whole of the open-market record (4 sales, €677k). Other entries cover 18 share grants and 11 option exercises.
The record was last updated on 20 April 2012 with a transaction in Seracare Life Sciences Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations